pharma · SH2B1 Deficiency Obesity · Prader-Willi Syndrome · SLNO
SOLENO THERAPEUTICS
SOLENO THERAPEUTICS INC
SOLENO THERAPEUTICS clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Redwood City, USA HQ
199 Employees
Public company Type
SLNO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Redwood City, USA
- Employees
- 199
- Programs
- 2
- Drugs
- 4
- Patents
- 0
SOLENO THERAPEUTICS projects
2 ClinicalTrials.gov programs sponsored by SOLENO THERAPEUTICS.
SOLENO THERAPEUTICS has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does SOLENO THERAPEUTICS have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.